Clinical trials
Parkinson clinical trials
Below are recruiting parkinson clinical trials, each written for real people, not researchers. We’re tracking 734 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07204652Recruiting
Colonoscopy test for Parkinson's disease detection
This study tests whether a protein in colon tissue can help diagnose Parkinson's disease. People with Parkinson's who already need a routine colonoscopy may participate.
Portland, OregonAges 40–99 - NCT06680830RecruitingPhase 2
Testing NEU-411 for early Parkinson's with LRRK2 gene change
This trial tests an experimental drug called NEU-411 for people with early Parkinson's disease who have a specific genetic change (LRRK2). It aims to see if the drug can slow the disease progression.
Sun City, ArizonaAges 40–80 - NCT07786116Recruiting
Gut bacteria in Parkinson's disease and related conditions
This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.
Cambridge, CB2Ages 55 years+ - NCT07217054Recruiting
Parkinson's and RBD diagnosis via colon biopsy
This trial uses a small piece of colon tissue, taken during a routine colonoscopy, to look for a protein linked to Parkinson's disease and REM sleep behavior disorder (RBD). It aims to improve diagnosis for these conditions.
Branford, ConnecticutAges 40–99 - NCT06705517Recruiting
Mediterranean diet study for Parkinson's disease
This trial tests whether a Mediterranean diet can help people with Parkinson's disease. You would either follow your usual diet or switch to a Mediterranean diet for six months and provide blood and stool samples.
Varese, VareseAges 40–85 - NCT07685873Recruiting
MAO-B PET imaging in Parkinson's and related diseases
This study uses a special type of brain scan (PET/CT) to look at a protein called MAO-B in people with Parkinson's disease or related conditions. The scan may help doctors understand more about the disease and could be part of your regular care.
Hefei, AnhuiAges 18–90 - NCT07630545RecruitingPhase 1
Testing a new drug for Parkinson's disease
This study tests an experimental drug, MTX325, in people with Parkinson's disease. The goal is to see if it is safe and how the body processes it, which may lead to new treatment options.
AdelaideAges 18–75 - NCT06174948Recruiting
CUE1 device for Parkinson's and related movement disorders
This trial tests a small device called CUE1 that gives gentle vibrations on the chest to help improve movement and balance in people with Parkinson's disease and similar conditions. It may help if you have trouble with walking or stability.
LondonAges 18 years+ - NCT07568067Recruiting
Accelerated Brain Stimulation for Parkinson's Disease
This trial tests a new type of brain stimulation (called temporal interference stimulation) targeted at specific brain regions to help improve Parkinson's disease symptoms. Researchers will use MRI imaging and behavioral assessments to see if this approach can reduce movement problems and improve quality of life.
Guangzhou, GuangdongAges Up to 85 years - NCT04994015Recruiting
Genetic registry for people with Parkinson’s
This study builds a genetics “registry” of people diagnosed with Parkinson’s disease who agree to genetic testing. Your information may help researchers understand why Parkinson’s happens and improve future treatments.
Birmingham, AlabamaAges 18 years+ - NCT04997642Recruiting
Parkinson’s patient database for memory and movement tracking
This study builds a research database of people who receive care for Parkinson’s disease, including those with mild memory problems or dementia. It aims to collect consistent information that researchers can use to better understand Parkinson’s and related thinking changes.
Philadelphia, PennsylvaniaAges 18 years+ - NCT02760108Recruiting
Parkinson’s Families Project for people with family links
This project is for people age 16 and older who have Parkinson’s (or similar symptoms called parkinsonism). It focuses on people with a family history and/or symptoms that started before age 45, to better understand Parkinson’s in families.
LondonAges 16 years+ - NCT05066763Recruiting
Surveys for people with Parkinson’s and their care partners
This trial is for people with Parkinson’s disease, their care partners, and health professionals who work with people with Parkinson’s. The Parkinson’s Foundation will contact you to collect survey information and may invite you to future research opportunities.
Miami, FloridaAges 18 years+ - NCT02194816Recruiting
Online survey study for people with Parkinson’s or Parkinsonism
This study looks at how changing certain factors over time relates to symptoms in Parkinson’s disease and related conditions. You may help researchers by completing longer online surveys every 6 months for 5 years.
Kenmore, WashingtonAges 19 years+ - NCT07840027RecruitingPhase 1
Vaccine for early Parkinson's disease
This study tests a new investigational vaccine called TRB-001 for people with early Parkinson's disease. It looks at whether the vaccine is safe and whether it can help the immune system fight the disease.
ViennaAges 40–75 - NCT07838636Recruiting
Exercise program for people with Parkinson's and a deep brain stimulator
This study tests whether a structured physical activity program can improve movement and quality of life for people with Parkinson's who have a deep brain stimulator (DBS) device. Half the participants will do the exercise program, and half will continue usual care, to see if exercise helps manage symptoms.
WarsawAges 50–70 - NCT07830654RecruitingPhase 2
Pet scan for Parkinson's disease
This study tests a new PET scan tracer called [18F]AV-133 to see if it can track Parkinson's disease over time. The scan may help doctors better understand the disease, and you would be part of the PPMI research program.
New Haven, ConnecticutAges 18 years+ - NCT07809438RecruitingPhase 2
Comparing PET scans for early Parkinson's detection
This study tests two different PET scan resolutions to see which is better at detecting signs of early Parkinson's. It is for people who are already part of a Parkinson's research study and may help improve early diagnosis.
New Haven, ConnecticutAges 18 years+ - NCT07797790Recruiting
Real-world experiences with Inbrija for Parkinson's OFF episodes
This study collects real-world experiences from people with Parkinson's disease who use Inbrija (an inhaled levodopa) to treat OFF episodes. Participants will share their experiences through surveys or interviews, which may help improve understanding of how Inbrija works in everyday life.
AltmünsterAges 18 years+ - NCT07761936RecruitingPhase 3
Safinamide for Parkinson's disease pain
This study tests whether safinamide, an add-on medication for Parkinson's disease, can reduce chronic pain in people who also experience motor fluctuations (times when symptoms return between doses). It aims to see if this treatment can improve pain and quality of life.
Verona, VenetoAges 18 years+ - NCT07752355Recruiting
Parkinson's subtypes and causes in young onset disease
This study looks at different types of Parkinson's disease, especially in people diagnosed before age 50. It involves a small skin biopsy to help understand what causes the disease.
New York, New YorkAges 18 years+ - NCT06640673Recruiting
Brain Wave Study for Mild Memory Problems and Parkinson's Disease
This study uses a special brain wave test (high-density EEG) to learn more about mild memory problems and how they might be linked to Parkinson's disease. If you join, you'll help researchers understand brain activity patterns that could lead to better diagnosis and care.
Lido, ItalyAges 50–90 - NCT07695233Recruiting
Ultrasound brain stimulation for freezing of gait in Parkinson's
This trial tests a noninvasive ultrasound treatment targeting a brain area called the pedunculopontine nucleus to help reduce freezing of gait (a sudden inability to walk) in Parkinson's disease. If you have Parkinson's and experience freezing, you may be eligible to try this new approach.
Toronto, OntarioAges 18–90 - NCT07629115Recruiting
Long-term follow-up study for severe Parkinson's gene therapy
This study follows patients who previously received IPS101A, an experimental gene therapy treatment for severe Parkinson's disease. Researchers want to check how you're doing over time and gather information about the treatment's long-term effects.
SeoulAges 50–80
Hear when a new Parkinson trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Parkinson trials by city
Studies with a site in or near these metro areas.
Parkinson trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for parkinson?
- Yes. Clin2 currently lists 734 recruiting parkinson studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.